Apr 21, 2020· Comment from The Association for Accessible Medicines (AAM)· FDA-2019-D-5585-0013
Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding FDA-2019-D-5585: Draft Guidance, Bridging for Drug-Device and Biologic-Device Combination Products.